The document is an intimation regarding the availability of an audio recording of a Conference call with Analysts/Investors discussing the company's Financial Results for the quarter and half year ended 30th September, 2026.
The disclosure is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The audio recording has been placed on the Company's website at the specific URL: https://www.torrentpharma.com/pdf/investors/Audio_Recording30092026.mp3
This communication is in continuation of a previous letter dated 9th October, 2026.
Additional Notes
The document is a formal compliance letter addressed to BSE Limited and National Stock Exchange of India Ltd.
No financial data, management participants, or specific discussion topics from the call are disclosed in this announcement.
The letter is digitally signed by CHINTAN M. TRIVEDI, Company Secretary, on October 23, 2026 at 19:30:21 IST.
